Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Mol Neurobiol ; 59(9): 5874-5890, 2022 Sep.
Article in English | MEDLINE | ID: mdl-35804280

ABSTRACT

Boswellia serrata gum is a natural product that showed beneficial effects on neurodegenerative diseases in recent studies. In this study, we investigated the effects of Boswellia serrata resin on rotenone-induced dopaminergic neurotoxicity. Firstly, we attempted to see if the resin can induce AMP-activated protein kinase (AMPK) signaling pathway which has been known to have broad neuroprotective effects. Boswellia increased AMPK phosphorylation and reduced phosphorylation of mammalian target of rapamycin (p-mTOR) and α-synuclein (p-α-synuclein) in the striatum while increased the expression level of Beclin1, a marker for autophagy and brain-derived neurotrophic factor. Next, we examined the neuroprotective effects of the Boswellia extract in the rotenone-injected mice. The results showed that Boswellia evidently attenuated the loss of the nigrostriatal dopaminergic neurons and microglial activation caused by rotenone. Moreover, Boswellia ameliorated rotenone-induced decrease in the striatal dopamine and impairment in motor function. Accumulation of α-synuclein meditated by rotenone was significantly ameliorated by Boswellia. Also, we showed that ß-boswellic acid, the active constituents of Boswellia serrata gum, induced AMPK phosphorylation and attenuated α-synuclein phosphorylation in SHSY5 cells. These results suggest that Boswellia protected the dopaminergic neurons from rotenone neurotoxicity via activation of the AMPK pathway which might be associated with attenuation of α-synuclein aggregation and neuroinflammation. Further investigations are warranted to identify specific molecules in Boswellia which are responsible for the neuroprotection.


Subject(s)
Boswellia , Neuroprotective Agents , Neurotoxicity Syndromes , AMP-Activated Protein Kinases/metabolism , Animals , Boswellia/metabolism , Dopamine/metabolism , Dopaminergic Neurons/metabolism , Mammals/metabolism , Methanol/metabolism , Methanol/pharmacology , Mice , Neuroprotective Agents/metabolism , Neuroprotective Agents/pharmacology , Neurotoxicity Syndromes/metabolism , Plant Extracts/metabolism , Plant Extracts/pharmacology , Rotenone/pharmacology , alpha-Synuclein/metabolism
2.
Molecules ; 26(13)2021 Jun 28.
Article in English | MEDLINE | ID: mdl-34203232

ABSTRACT

Colorectal cancer is one of the life-threatening ailments causing high mortality and morbidity worldwide. Despite the innovation in medical genetics, the prognosis for metastatic colorectal cancer in patients remains unsatisfactory. Recently, lichens have attracted the attention of researchers in the search for targets to fight against cancer. Lichens are considered mines of thousands of metabolites. Researchers have reported that lichen-derived metabolites demonstrated biological effects, such as anticancer, antiviral, anti-inflammatory, antibacterial, analgesic, antipyretic, antiproliferative, and cytotoxic, on various cell lines. However, the exploration of the biological activities of lichens' metabolites is limited. Thus, the main objective of our study was to evaluate the anticancer effect of secondary metabolites isolated from lichen (Usnea barbata 2017-KL-10) on the human colorectal cancer cell line HCT116. In this study, 2OCAA exhibited concentration-dependent anticancer activities by suppressing antiapoptotic genes, such as MCL-1, and inducing apoptotic genes, such as BAX, TP53, and CDKN1A(p21). Moreover, 2OCAA inhibited the migration and invasion of colorectal cancer cells in a concentration-dependent manner. Taken together, these data suggest that 2OCAA is a better therapeutic candidate for colorectal cancer.


Subject(s)
Antineoplastic Agents , Apoptosis/drug effects , Colorectal Neoplasms/drug therapy , Triterpenes , Usnea/chemistry , Antineoplastic Agents/chemistry , Antineoplastic Agents/pharmacology , Colorectal Neoplasms/metabolism , HCT116 Cells , Humans , Triterpenes/chemistry , Triterpenes/pharmacology
3.
Arch Pharm Res ; 35(3): 481-6, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22477195

ABSTRACT

Fatty acid synthase (FAS) is considered as a novel drug target for the development of anticancer and anti-obesity agents. Bioassay-guided fractionation of a n-hexane-soluble extract prepared from the roots of Salvia miltiorrhiza Bunge (Labiatae), using an in vitro enzyme assay, led to the isolation of five abietane diterpenoids: 15,16-dihydrotanshinone I (1), cryptotanshinone (2), tanshinone I (3), tanshinone IIA (4), and dansenspiroketallactone (5). Compounds 1-5 were tested for their in vitro FAS inhibitory activity and, except for compound 5 (IC(50) > 100 µM), compounds 1-4 inhibited the enzyme activity with IC(50) values ranging from 12.0 to 30.3 µM. Our findings may be partially related to the anticancer activity of abietane diterpenoids from the plant, suggesting a further study on the anticancer potential of tanshinone derivatives.


Subject(s)
Abietanes/isolation & purification , Abietanes/pharmacology , Antineoplastic Agents, Phytogenic/isolation & purification , Antineoplastic Agents, Phytogenic/pharmacology , Biological Assay , Chemical Fractionation/methods , Fatty Acid Synthases/antagonists & inhibitors , Fatty Acid Synthesis Inhibitors/isolation & purification , Fatty Acid Synthesis Inhibitors/pharmacology , Salvia miltiorrhiza/chemistry , Abietanes/chemistry , Animals , Cell Proliferation/drug effects , Chromatography, High Pressure Liquid , Dose-Response Relationship, Drug , Fatty Acid Synthases/metabolism , Fatty Acid Synthesis Inhibitors/chemistry , HL-60 Cells , Hexanes/chemistry , Humans , Inhibitory Concentration 50 , Magnetic Resonance Spectroscopy , Plant Roots , Rats , Solvents/chemistry , Spectrophotometry, Ultraviolet
SELECTION OF CITATIONS
SEARCH DETAIL
...